Andrew Dudum - 06 Jun 2023 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
06 Jun 2023
Net transactions value
-$477,335
Form type
4
Filing time
08 Jun 2023, 19:40:52 UTC
Previous filing
08 Jun 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $4,882 +2,009 +0.52% $2.43 385,947 06 Jun 2023 Direct F1
transaction HIMS Class A Common Stock Options Exercise $174,797 +71,933 +19% $2.43 457,880 06 Jun 2023 Direct F1
transaction HIMS Class A Common Stock Sale $657,014 -71,933 -16% $9.13 385,947 06 Jun 2023 Direct F2, F3
holding HIMS Class A Common Stock 1,695,815 06 Jun 2023 Held by Trustee of AD 2022 GRAT 3
holding HIMS Class A Common Stock 359,947 06 Jun 2023 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 2,643,348 06 Jun 2023 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 700,000 06 Jun 2023 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 81,100 06 Jun 2023 Held by Trustee of Dudum Family Community Property Trust
holding HIMS Class A Common Stock 660,837 06 Jun 2023 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 1,047,164 06 Jun 2023 Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022
holding HIMS Class A Common Stock 1,500 06 Jun 2023 Held by Trustees of Richard M. Dudum Irrevocable 1 U/A dtd 10/15/1997
holding HIMS Class A Common Stock 1,121,033 06 Jun 2023 Held by Trustee of the AD GRAT dated 8/31/20
holding HIMS Class A Common Stock 2,874,769 06 Jun 2023 Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -2,009 -0.06% $0.000000 3,206,248 06 Jun 2023 Class A Common Stock 2,009 $2.43 Direct F4
transaction HIMS Stock Option (right to buy) Options Exercise $0 -71,933 -2.2% $0.000000 3,134,315 06 Jun 2023 Class A Common Stock 71,933 $2.43 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.
F2 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2023 by the Reporting Person.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.00 - $9.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.